Search

Your search keyword '"Arabi Y.M."' showing total 31 results

Search Constraints

Start Over You searched for: Author "Arabi Y.M." Remove constraint Author: "Arabi Y.M."
31 results on '"Arabi Y.M."'

Search Results

1. Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial.

2. Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support-Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial.

3. Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.

4. Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial

5. Infection control in the intensive care unit: expert consensus statements for SARS-CoV-2 using a Delphi method

6. Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19

8. Effect of Convalescent Plasma on Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial

9. Viewpoint of a WHO Advisory Group Tasked to Consider Establishing a Closely-monitored Challenge Model of Coronavirus Disease 2019 (COVID-19) in Healthy Volunteers

10. Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19

11. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19

12. Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial

13. Early sedation with dexmedetomidine in ventilated critically ill patients and heterogeneity of treatment effect in the SPICE III randomised controlled trial.

14. Effect of Convalescent Plasma on Organ Support-Free Days in Critically Ill Patients with COVID-19: A Randomized Clinical Trial.

16. Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE) randomised clinical trial: Study protocol.

17. Association between minimum inhibitory concentration, beta-lactamase genes and mortality for patients treated with piperacillin/tazobactam or meropenem from the MERINO study.

18. The effect of dexmedetomidine on vasopressor requirements in patients with septic shock: A subgroup analysis of the Sedation Practice in Intensive Care Evaluation [SPICE III] Trial.

19. Patient Outcomes at Twelve Months after Early Decompressive Craniectomy for Diffuse Traumatic Brain Injury in the Randomized DECRA Clinical Trial

20. Early sedation with dexmedetomidine in critically ill patients.

22. Recovery after critical illness: putting the puzzle together-a consensus of 29

23. Time-limited trials of intensive care for critically Ill patients with cancer

25. Microbiology of Community-Acquired Pneumonia in the Gulf Corporation Council States

26. Management and Prevention Strategies for Community-Acquired Pneumonia in the Gulf Corporation Council

27. Clinical Presentation and Diagnostic Workup for Community-Acquired Pneumonia: The Gulf Corporation Council CAP Working Group Consensus Statement

29. Resolved versus confirmed ARDS after 24 h: insights from the LUNG SAFE study

30. Outcomes of Patients Presenting with Mild Acute Respiratory Distress Syndrome: Insights from the LUNG SAFE Study

31. Noninvasive Ventilation of Patients with Acute Respiratory Distress Syndrome: Insights from the LUNG SAFE Study

Catalog

Books, media, physical & digital resources